Health Condition 1: G400- Localization-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localized onset Health Condition 2: G401- Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures Health Condition 3: G402- Localization-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures Health Condition 4: G403- Generalized idiopathic epilepsy and epileptic syndrom
Conditions
Interventions
Intervention1: nil: nil
Control Intervention1: nil: nil
Sponsors
None
Eligibility
Inclusion criteria
Inclusion criteria: •All patients with pharmaco-resistant epilepsy who undergo epilepsy surgery as determined by the multidisciplinary pre-surgical epilepsy patient management conference ( PMC). • Patients who are interested to participate in the study.
Exclusion criteria
Exclusion criteria: Patients who are already controlled with anticonvulsant drug treatment. • Participants who are not willing to sign the informed consent document.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| seizure outcome Timepoint: 3 ,6 and 12 months and yearly follow up- up to 5 years | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. correlation of seizure outcome with individual imaging modalities 2. correlation of seizure outcome with image post-processing analysis 3. correlation of seizure outcome with pathology 4. quality of life assessment using standardized scales (QOLIE 31, etc.)Timepoint: 3 ,6 and 12 months and yearly follow up- up to 5 years | — |
Countries
India
Contacts
Public ContactDr Ashok Pillai
Amrita Institute of medical sciences and research centre
Outcome results
None listed